Export this Abstract | Print this Abstract | Add to my preferred Abstracts list | My preferred Abstracts list (0) | Back to Search
A description of how and why EPAs were developed in the Netherlands and the USA
- At: 2018 FIP Congress in Glasgow (Scotland)
- Type: Presentation
- By: WESTEIN, Marnix (KNMP, The Netherlands)
- Co-author(s): Marnix Westein:,Knmp - Royal Dutch Pharmacists Association,Den Haag,Netherlands;Utrecht Institute of Pharmaceutical Sciences,Utrecht University,Utrecht,Netherlands
The abstract has already been submitted by Amy Pittenger and/or Lucinda Maine... The access to the whole abstract and the presentation file is available to FIP members and to congress participants of that specific congress.
Last update 4 October 2019